Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BRCA Reimbursement Cut Heightens Tensions Between CMS And Lab Industry

10 Feb 2014

Related Content

Personalized Medicine And Palmetto’s MolDx: Raising The Bar On Evidence

03 Dec 2012

Molecular Dx Labs Fret Over Medicare Payment Setting, Or, In Some Cases, Lack Thereof

08 Apr 2013

Quest Enters Market For BRCA Gene Testing

21 Oct 2013

Diagnostic Companies Rush To Test Formerly Off-Limit Genes

24 Jun 2013

Molecular Dx Labs’ Concerns Shift To Coverage Issues With Release Of Interim Medicare Payment Amounts

03 Jun 2013

News Briefs: Lung Screening Recs; Stryker Purchase; CMS News

06 Jan 2014

Related Companies

Myriad Genetics, Inc.

Additional Topics

United States Reimbursement Medical Device

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.